Clinical Trial Update: Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects

View source ↗

Summary

This is a clinical trial update about a cardiovascular risk evaluation in subjects with Type 2 Diabetes Mellitus. The study sponsored by GlaxoSmithKline has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: GlaxoSmithKline | Conditions: Type 2 Diabetes Mellitus, CV Risk | Status: COMPLETED